Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients

被引:52
作者
Aisenberg, J
Legnani, PE
Nilubol, N
Cobrin, GM
Ellozy, SH
Hegazi, RAF
Yager, J
Bodian, C
Gorfine, SR
Bauer, JJ
Plevy, S
Sachar, DB
机构
[1] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15261 USA
[2] Mt Sinai Med Ctr, Dept Gastroenterol, New York, NY 10029 USA
[3] Mt Sinai Med Ctr, Dept Gen Surg, New York, NY 10029 USA
[4] Mt Sinai Med Ctr, Dept Biomath, New York, NY 10029 USA
[5] NYU Med Ctr, Dept Med, New York, NY 10016 USA
关键词
D O I
10.1111/j.1572-0241.2004.04107.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Pouchitis is the most frequent complication after ileal pouch-anal anastomosis for ulcerative colitis. This study alms to analyze the frequency and characteristics of pouchitis in long-term follow-up in a large population, and to determine whether a significant association exists between five immunogenetic markers and pouchitis. Methods: From a population of over 500 ulcerative colitis patients who had undergone ileal pouch-anal anastamosis 5-12 yr earlier, 102 subjects participated in the study. Using clinical data obtained from interviews and chart reviews, patients were classified into three groups: no pouchitis; 1-2 episodes per year; and >2 episodes per year. Coded sera from the patients were analyzed for ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies and Crohn's disease-associated anti-saccharomyces cerevesiae antibodies. Interleukin-1 receptor antagonist, tumor necrosis factor (TNF), and lymphotoxin beta (lymphotoxin) polymorphisms were also analyzed. Results: Pouchitis affected 49% of the study population. Antineutrophil cytoplasmic antibodies, anti-saccharomyces cerevesiae antibodies, and lymphotoxin-beta polymorphisms were not associated with pouchitis. Carriage of interleukin-1 receptor antagonist allele 2 was significantly greater among those without pouchitis than those with pouchitis. Patients without pouchitis had a significantly greater carriage rate of TNF allele 2. Conclusions: Perinuclear antineutrophil cytoplasmic antibodies and anti-saccharomyces cerevesiae antibodies are not correlated with pouchitis, but interleukin-1 receptor antagonist and TNF may play a role in its development. Further evaluation of these markers in pouchitis will require larger populations, long-term prospective observation, and studies that correlate polymorphisms with specific immunologic functions.
引用
收藏
页码:432 / 441
页数:10
相关论文
共 41 条
[1]
PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY AND REFRACTORY POUCHITIS - A CASE-CONTROL STUDY [J].
AISENBERG, J ;
WAGREICH, J ;
SHIM, J ;
ALMER, S ;
PEEN, E ;
HEIMANN, T ;
GELERNT, IM ;
GREENSTEIN, A ;
RUBIN, P ;
HARPAZ, N ;
MAYER, L ;
SACHAR, D .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (09) :1866-1872
[2]
Evidence for genetic heterogeneity in IBD .1. The interleukin-2 receptor antagonist in the predisposition to suffer from ulcerative colitis [J].
Bioque, G ;
Bouma, G ;
Crusius, JBA ;
Koutroubakis, I ;
Kostense, PJ ;
Meuwissen, SGM ;
Pena, AS .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (02) :105-110
[3]
Genetic and immunological markers in pouchitis [J].
Brett, PM ;
Yasuda, N ;
Yiannakou, JY ;
Herbst, F ;
Ellis, HJ ;
Vaughan, R ;
Nicholls, RJ ;
Ciclitira, PJ .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (10) :951-955
[4]
The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis [J].
Carter, MJ ;
Di Giovine, FS ;
Cox, A ;
Goodfellow, P ;
Jones, S ;
Shorthouse, AJ ;
Duff, GW ;
Lobo, AJ .
GASTROENTEROLOGY, 2001, 121 (04) :805-811
[5]
CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
[6]
Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease [J].
Cominelli, F ;
Pizarro, TT .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 :49-53
[7]
*CYT SOFTW CORP, STATXACT 4 WIND
[8]
DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303
[9]
Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications [J].
Facklis, K ;
Plevy, SE ;
Vasiliauskas, EA ;
Kam, L ;
Taylor, K ;
Targan, SR ;
Fleshner, PR .
DISEASES OF THE COLON & RECTUM, 1999, 42 (05) :601-605
[10]
Fleshner PR, 1999, GASTROENTEROLOGY, V116, pA716